Mark A. Rubin, M.D.

Anatomic Pathology and Clinical Pathology

Default Image

Dr. Mark A. Rubin, Professor of Pathology and Laboratory Medicine, serves as Vice Chairman for Experimental Pathology and Director, Translational Research Laboratory Services. Dr. Mark Rubin received his M.D. from Mount Sinai Medical Center and completed training in anatomic pathology at Georgetown University Medical Center followed by a clinical fellowship in anatomic pathology at Johns Hopkins Hospital. His first academic appointment was Assistant Professor of Pathology at Columbia University College of Physicians and Surgeons, followed by Associate Professor of Pathology with Tenure at the University of Michigan and most recently as Associate Professor of Pathology at Harvard Medical School.

Dr. Mark Rubin is one of the foremost academic anatomic pathologists in the United States. He is widely recognized for his clinical diagnostic expertise in prostate pathology. Most recently, he served as Chief of Urologic Pathology at The Brigham and Womenᅡメs Hospital. He has received the two most prestigious awards granted by professional pathology organizations to young investigators. He was awarded the Arthur Purdy Stout Society of Surgical Pathologists Annual Prize in 2003 and the Young Investigator Award from the United States and Canadian Academy of Pathology in 2004, in each case recognizing him as the most prominent pathologist in the United States under the age of 45.

Dr. Rubin is a practicing genitourinary pathologist. The focus of Dr. Rubinᅡメ's laboratory-based research for the past 10 years has been the development of molecular prostate cancer biomarkers to help distinguish indolent from aggressive disease. In collaboration with Arul Chinnaiyanᅡメ's laboratory at the University of Michigan, they identified a common recurrent gene fusion between the TMPRSS2 and ETS genes in the majority of prostate cancers. His work relies on close collaboration with researchers in the fields of urology, medical oncology, clinical outcomes, and molecular biology. His laboratory uses a variety of techniques including RT-PCR, laser capture microdissection, high-density tissue microarrays, SNP arrays, tiling arrays, and cDNA expression arrays in combination with clinical and pathology parameters to identify significant associations. See http://rubinlab.med.cornell.edu/.

Dr. Mark Rubin received his M.D. from Mount Sinai Medical Center and completed training in anatomic pathology at Georgetown University Medical Center followed by a clinical fellowship in anatomic pathology at Johns Hopkins Hospital. His first academic appointment was Assistant Professor of Pathology at Columbia University College of Physicians and Surgeons, followed by Associate Professor of Pathology with Tenure at the University of Michigan and most recently as Associate Professor of Pathology at Harvard Medical School.

Dr. Mark Rubin is one of the foremost academic anatomic pathologists in the United States. He is widely recognized for his clinical diagnostic expertise in prostate pathology.

Back to topBack To Top